WaveMan · Form 4
Behbahani Ali insider trades
> Search tickers & screens ⌘K
LIVE

Behbahani Ali insider trades

Behbahani Ali has filed 94 Form 4s with the SEC that we hold, for Black Diamond Therapeutics, Inc. (BDTX) (Director), NEUE (Director, 10% owner), ACLX (Director) and CRISPR Therapeutics AG (CRSP) (Director), among 19 companies in all. Across all of them we count 7 purchases worth $35.8M and 11 sales worth $2.3M reported on Form 4. In the last 12 months: 1 purchase ($15.0M) and 1 sale ($780.9K). The largest single trade was a purchase of 937,500 shares of SpyGlass Pharma, Inc. worth $15.0M, dated 2026-02-09. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-01 and the latest 2026-09-21.

Black Diamond Therapeutics, Inc. (BDTX)

Director · 27 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-07-05P, purchase reported on Form 41,000,000$5.0M2023-07-06

NEUE

Director, 10% owner · 9 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-10-02S, sale reported on Form 42,455$16.6K2025-10-06
2025-10-02S, sale reported on Form 4280$1.9K2025-10-06
2025-10-02S, sale reported on Form 4900$6.1K2025-10-06

ACLX

Director · 7 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CRISPR Therapeutics AG (CRSP)

Director · 7 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-09-17S, sale reported on Form 413,679$780.9K2026-09-21

Adaptimmune Therapeutics PLC (ADAP)

Director · 6 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-08-15S, sale reported on Form 44,828,206$48.3K2025-08-19
2025-08-18S, sale reported on Form 414,671,794$146.7K2025-08-19

CVRx, Inc. (CVRX)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Korro Bio, Inc. (KRRO)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Monte Rosa Therapeutics, Inc. (GLUE)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Nkarta, Inc. (NKTX)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Trevi Therapeutics, Inc. (TRVI)

10% owner · 3 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-18P, purchase reported on Form 41,851,852-2021-10-19
2022-04-11P, purchase reported on Form 42,631,578$5.0M2022-04-13
2022-04-11P, purchase reported on Form 4948,948$1.8M2022-04-13

GNCA

Director, 10% owner · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-24S, sale reported on Form 45,931,843$415.2K2022-05-26
2022-05-25S, sale reported on Form 44,445,093$355.6K2022-05-26

OYST

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

SpyGlass Pharma, Inc. (SGP)

Director, 10% owner · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-02-09P, purchase reported on Form 4937,500$15.0M2026-02-11

UTRS

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

AKUS

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MBX Biosciences, Inc. (MBX)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-09-16P, purchase reported on Form 4500,000$8.0M2024-09-17

MTCR

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-10S, sale reported on Form 437,570$49.6K2021-12-27
2021-12-22S, sale reported on Form 4288,768$288.8K2021-12-27
2021-12-22S, sale reported on Form 4170,932$155.5K2021-12-27

Mirum Pharmaceuticals, Inc. (MIRM)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Savara Inc (SVRA)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-07-17P, purchase reported on Form 4333,333$1,000.0K2023-07-19
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1613867) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms